Histamine-1 Receptor Antagonist [EPC]

Histamine-1 Receptor Antagonist [EPC] was reported 84381 times

Drugs of the Histamine-1 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 GRIP STRENGTH 124 0.5415
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 358 0.5359
2 SWOLLEN JOINT COUNT 129 0.5160
3 VAGINAL FLATULENCE 154 0.5083
4 LUPUS VULGARIS 543 0.4310
5 C-REACTIVE PROTEIN 396 0.4272
6 DEEP VEIN THROMBOSIS POSTOPERATIVE 827 0.4129
7 DUODENAL ULCER PERFORATION 2953 0.3967
8 SWOLLEN JOINT COUNT INCREASED 1232 0.3860
9 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 2707 0.3774
10 RHEUMATIC FEVER 1681 0.3767
11 FACET JOINT SYNDROME 1220 0.3743
12 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 679 0.3274
13 MUSCLE INJURY 2689 0.3242
14 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1979 0.3044
15 RETINITIS 512 0.2961
16 DISLOCATION OF VERTEBRA 676 0.2961
17 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 161 0.2870
18 FOLLICULITIS 2984 0.2843
19 HELICOBACTER INFECTION 2916 0.2834
20 CARDIOSPASM 156 0.2796
21 PEMPHIGUS 3399 0.2716
22 RHEUMATOID FACTOR POSITIVE 1563 0.2703
23 BLOOD PRESSURE DIASTOLIC ABNORMAL 673 0.2643
24 X-RAY ABNORMAL 472 0.2637
25 BLOOD PRESSURE SYSTOLIC ABNORMAL 639 0.2583
26 HAND DEFORMITY 3110 0.2369
27 NEUROLOGIC NEGLECT SYNDROME 131 0.2356
28 PERIPHERAL VENOUS DISEASE 914 0.2236
29 IMMUNISATION 96 0.2212
30 HYPOCHOLESTEROLAEMIA 73 0.2068
31 PALMOPLANTAR KERATODERMA 148 0.2041
32 C-REACTIVE PROTEIN ABNORMAL 1250 0.1947
33 SERONEGATIVE ARTHRITIS 221 0.1928
34 PERICARDITIS 3202 0.1904
35 SYNOVITIS 3222 0.1785
36 TEMPERATURE REGULATION DISORDER 393 0.1762
37 INFUSION SITE DISCHARGE 301 0.1715
38 PORPHYRIA ACUTE 225 0.1568
39 CAROTID ARTERY THROMBOSIS 130 0.1531
40 BREAST CANCER STAGE III 952 0.1468
41 GLOSSODYNIA 3261 0.1455
42 IRRITABLE BOWEL SYNDROME 3050 0.1421
43 BONE EROSION 487 0.1376
44 OVERLAP SYNDROME 95 0.1357
45 LIP DRY 1173 0.1290
46 BURSITIS 1531 0.1261
47 ELECTRIC SHOCK 103 0.1202
48 JOINT RANGE OF MOTION DECREASED 1584 0.1180
49 WOUND INFECTION 1288 0.1175
50 HYPERCHOLESTEROLAEMIA 1122 0.1161
51 INFUSION SITE MASS 123 0.1132
52 WOUND 3128 0.1118
53 CHRONIC SPONTANEOUS URTICARIA 124 0.1069
54 ADJUSTMENT DISORDER 136 0.1046
55 DEATH NEONATAL 145 0.1042
56 GRIP STRENGTH DECREASED 916 0.1040
57 GRANULOMATOSIS WITH POLYANGIITIS 121 0.1002
58 SYSTEMIC LUPUS ERYTHEMATOSUS 3559 0.1002
59 ONYCHOMADESIS 420 0.1000
60 IMPAIRED HEALING 3208 0.0976
61 AUTOIMMUNE DISORDER 937 0.0960
62 LIVE BIRTH 798 0.0953
63 INFUSION SITE BRUISING 206 0.0953
64 JOINT DESTRUCTION 148 0.0951
65 INFUSION RELATED REACTION 6309 0.0951
66 CHRONIC SINUSITIS 354 0.0942
67 FEMALE GENITAL TRACT FISTULA 160 0.0936
68 BLEPHAROSPASM 590 0.0936
69 DRUG TOLERANCE DECREASED 259 0.0921
70 INFUSION SITE REACTION 273 0.0913
71 CONTRAINDICATED PRODUCT ADMINISTERED 2721 0.0898
72 INFUSION SITE PRURITUS 283 0.0896
73 FIBROMYALGIA 2121 0.0872
74 BLOOD PRESSURE DIASTOLIC DECREASED 603 0.0816
75 MATERNAL EXPOSURE TIMING UNSPECIFIED 292 0.0777
76 PRURITUS GENITAL 183 0.0776
77 FOOD ALLERGY 599 0.0775
78 INFUSION SITE HAEMORRHAGE 251 0.0762
79 LOWER RESPIRATORY TRACT INFECTION 3460 0.0760
80 ATRIAL TACHYCARDIA 159 0.0756
81 ONYCHOMYCOSIS 319 0.0726
82 OBESITY 1120 0.0702
83 TYPE 2 DIABETES MELLITUS 2296 0.0681
84 ANTICHOLINERGIC SYNDROME 107 0.0671
85 RADICULOPATHY 177 0.0671
86 EXOSTOSIS 609 0.0666
87 PROCTITIS 186 0.0663
88 RED BLOOD CELL SEDIMENTATION RATE INCREASED 717 0.0647
89 WALKING AID USER 427 0.0647
90 ARTHROPATHY 3590 0.0645
91 LIVER INJURY 1559 0.0634
92 COELIAC DISEASE 619 0.0630
93 SCIATICA 1003 0.0629
94 INFUSION SITE RASH 86 0.0626
95 MULTIPLE ALLERGIES 483 0.0616
96 BLOOD PRESSURE SYSTOLIC INCREASED 1198 0.0614
97 BLISTER 3413 0.0607
98 MAST CELL ACTIVATION SYNDROME 85 0.0605
99 PHARYNGEAL PARAESTHESIA 96 0.0605
100 INTERVERTEBRAL DISCITIS 113 0.0599
101 BLOOD PRESSURE DIASTOLIC INCREASED 276 0.0597
102 THERAPEUTIC PRODUCT EFFECT DECREASED 2677 0.0597
103 INFUSION SITE SWELLING 366 0.0581
104 PERSONALITY DISORDER 151 0.0576
105 FOOT DEFORMITY 624 0.0562
106 STOMATITIS 3367 0.0555
107 PRESCRIBED OVERDOSE 1065 0.0550
108 HEPATIC ENZYME INCREASED 3718 0.0545
109 NAIL DISORDER 474 0.0541
110 ORAL PRURITUS 124 0.0540
111 MACULAR DEGENERATION 643 0.0538
112 FINGER DEFORMITY 257 0.0530
113 LUPUS-LIKE SYNDROME 481 0.0530
114 PULMONARY PAIN 154 0.0527
115 EAR PRURITUS 184 0.0524
116 BLOOD PRESSURE FLUCTUATION 1249 0.0520
117 SEASONAL ALLERGY 736 0.0519
118 SINUSITIS 5284 0.0515
119 PULMONARY FIBROSIS 984 0.0512
120 NONINFECTIVE GINGIVITIS 73 0.0504
121 PUSTULAR PSORIASIS 172 0.0500
122 PSORIATIC ARTHROPATHY 2012 0.0495
123 JOINT DISLOCATION 519 0.0490
124 SLEEP TERROR 206 0.0489
125 SPONDYLITIS 176 0.0484
126 DEVICE INFUSION ISSUE 119 0.0479
127 RHEUMATOID ARTHRITIS 5446 0.0479
128 INCORRECT DRUG ADMINISTRATION RATE 204 0.0479
129 LOWER LIMB FRACTURE 908 0.0472
130 FOETAL DEATH 245 0.0472
131 DISCOMFORT 2877 0.0471
132 WHITE BLOOD CELLS URINE POSITIVE 88 0.0467
133 SWELLING 4340 0.0463
134 NIGHT SWEATS 1471 0.0456
135 INSURANCE ISSUE 698 0.0456
136 ILL-DEFINED DISORDER 2772 0.0456
137 IMMUNODEFICIENCY 676 0.0453
138 HIP ARTHROPLASTY 690 0.0450
139 CAROTID ARTERY OCCLUSION 161 0.0441
140 BLOOD CHOLESTEROL INCREASED 2014 0.0432
141 JOINT SWELLING 5187 0.0429
142 INFUSION SITE ERYTHEMA 362 0.0429
143 BACK INJURY 466 0.0428
144 WHEEZING 2540 0.0428
145 TENSION HEADACHE 181 0.0421
146 OSTEOARTHRITIS 1777 0.0419
147 EAR INFECTION 1111 0.0417
148 RASH VESICULAR 201 0.0415
149 INFUSION SITE PAIN 532 0.0412
150 CONGENITAL ANOMALY 318 0.0410
151 BLOOD IMMUNOGLOBULIN E INCREASED 98 0.0404
152 BODY TEMPERATURE DECREASED 397 0.0403
153 GAIT INABILITY 1338 0.0400
154 MUSCLE SPASTICITY 485 0.0394
155 C-REACTIVE PROTEIN INCREASED 1430 0.0393
156 POOR VENOUS ACCESS 400 0.0386
157 EAR PAIN 742 0.0381
158 UPPER RESPIRATORY TRACT INFECTION 1719 0.0372
159 TENOSYNOVITIS 102 0.0369
160 KNEE ARTHROPLASTY 770 0.0365
161 DRUG TOLERANCE 185 0.0365
162 RESPIRATORY RATE INCREASED 319 0.0359
163 MONOCYTE COUNT INCREASED 129 0.0355
164 DRUG INTOLERANCE 3399 0.0352
165 BREAST CANCER STAGE II 289 0.0347
166 SINUS CONGESTION 469 0.0347
167 GASTROINTESTINAL DISORDER 3094 0.0345
168 INFLAMMATION 1746 0.0338
169 APLASTIC ANAEMIA 176 0.0337
170 INFUSION SITE EXTRAVASATION 209 0.0335
171 SLEEP DISORDER 2321 0.0329
172 RHINITIS ALLERGIC 146 0.0328
173 OBSTRUCTION 130 0.0325
174 ULCER HAEMORRHAGE 220 0.0325
175 BODY TEMPERATURE INCREASED 663 0.0325
176 FORCED EXPIRATORY VOLUME DECREASED 92 0.0324
177 LABYRINTHITIS 80 0.0316
178 BLOOD PRESSURE SYSTOLIC DECREASED 142 0.0312
179 CONTUSION 2996 0.0311
180 BLOOD IMMUNOGLOBULIN G DECREASED 77 0.0310
181 SPINAL FUSION SURGERY 126 0.0310
182 DEMYELINATION 127 0.0310
183 WEIGHT FLUCTUATION 323 0.0308
184 LUNG DISORDER 1512 0.0308
185 OXYGEN SATURATION DECREASED 1732 0.0308
186 TASTE DISORDER 623 0.0307
187 NASOPHARYNGITIS 5654 0.0306
188 INJURY 2144 0.0305
189 INTENTIONAL PRODUCT USE ISSUE 2668 0.0304
190 INFECTION 4403 0.0304
191 VASCULITIS 354 0.0304
192 HEART RATE DECREASED 1066 0.0303
193 ROAD TRAFFIC ACCIDENT 1268 0.0303
194 MATERNAL EXPOSURE DURING PREGNANCY 2685 0.0301
195 HEPATIC CIRRHOSIS 565 0.0300
196 MOBILITY DECREASED 2155 0.0300
197 DERMATITIS CONTACT 341 0.0299
198 PRODUCT LABEL CONFUSION 173 0.0297
199 SKIN LACERATION 321 0.0295
200 PERIPHERAL SWELLING 4541 0.0294
201 GANGRENE 177 0.0293
202 FACIAL PAIN 262 0.0293
203 OEDEMA 1578 0.0291
204 TYPE I HYPERSENSITIVITY 102 0.0290
205 RHINITIS 232 0.0287
206 LIVER FUNCTION TEST INCREASED 616 0.0287
207 JOINT STIFFNESS 750 0.0286
208 PREGNANCY 568 0.0283
209 MUSCULOSKELETAL STIFFNESS 2461 0.0281
210 HYPERSENSITIVITY 5199 0.0280
211 DELIRIUM 970 0.0279
212 MUSCULOSKELETAL PAIN 1460 0.0278
213 RESPIRATORY DISORDER 832 0.0278
214 PRESCRIBED UNDERDOSE 551 0.0276
215 ADRENAL INSUFFICIENCY 335 0.0276
216 RESPIRATORY TRACT INFECTION 715 0.0274
217 VITAMIN B12 DECREASED 79 0.0274
218 RHEUMATOID NODULE 75 0.0272
219 EPILEPSY 828 0.0271
220 PARAESTHESIA ORAL 390 0.0270
221 URTICARIA 4512 0.0269
222 SKIN ABRASION 127 0.0268
223 ARTERIAL OCCLUSIVE DISEASE 211 0.0268
224 ABDOMINAL DISCOMFORT 4481 0.0267
225 NORMAL NEWBORN 142 0.0261
226 SUSPECTED OFF LABEL USE 118 0.0261
227 DRY MOUTH 2111 0.0260
228 TREATMENT FAILURE 2154 0.0260
229 EYE INJURY 77 0.0253
230 ASTHMA 2854 0.0252
231 MULTIPLE DRUG OVERDOSE 125 0.0252
232 MYOSITIS 224 0.0249
233 COORDINATION ABNORMAL 347 0.0249
234 POLYARTHRITIS 131 0.0248
235 SINUS DISORDER 492 0.0248
236 PARANASAL SINUS DISCOMFORT 94 0.0248
237 PRODUCT DISTRIBUTION ISSUE 228 0.0246
238 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 416 0.0245
239 BRONCHIECTASIS 165 0.0245
240 SENSORY LOSS 196 0.0243
241 GENERAL PHYSICAL HEALTH DETERIORATION 2798 0.0242
242 ANGIOEDEMA 1062 0.0240
243 THERAPY NON-RESPONDER 1075 0.0239
244 GASTROENTERITIS VIRAL 430 0.0238
245 OSTEOPOROSIS 976 0.0237
246 CONFUSIONAL STATE 3830 0.0237
247 PNEUMONIA VIRAL 75 0.0235
248 WEIGHT INCREASED 5213 0.0233
249 ORAL CANDIDIASIS 306 0.0232
250 LIVER DISORDER 1016 0.0229
251 RESPIRATORY TRACT CONGESTION 363 0.0228
252 POST-TRAUMATIC STRESS DISORDER 152 0.0227
253 PHARYNGEAL SWELLING 221 0.0226
254 BRONCHITIS 1639 0.0221
255 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 120 0.0220
256 DRUG-INDUCED LIVER INJURY 690 0.0220
257 THROAT IRRITATION 983 0.0219
258 SUBARACHNOID HAEMORRHAGE 223 0.0219
259 SYNOVIAL CYST 101 0.0219
260 EXPOSURE DURING PREGNANCY 1358 0.0218
261 DRUG TOXICITY 296 0.0217
262 JOINT EFFUSION 149 0.0216
263 RALES 125 0.0215
264 MIGRAINE 2027 0.0212
265 UPPER-AIRWAY COUGH SYNDROME 174 0.0211
266 RED CELL DISTRIBUTION WIDTH INCREASED 87 0.0209
267 EYE INFECTION 235 0.0208
268 RHINOVIRUS INFECTION 81 0.0208
269 ALOPECIA 4087 0.0208
270 OBSTRUCTIVE AIRWAYS DISORDER 230 0.0207
271 NEPHROGENIC ANAEMIA 95 0.0205
272 TENDERNESS 210 0.0201
273 PHARYNGITIS STREPTOCOCCAL 218 0.0201
274 MYDRIASIS 258 0.0201
275 TOOTH INFECTION 265 0.0201
276 SKIN INFECTION 224 0.0199
277 GENERAL SYMPTOM 149 0.0199
278 TOOTH ABSCESS 202 0.0198
279 LIP SWELLING 658 0.0197
280 HYPERTENSION 4166 0.0196
281 CYSTITIS 622 0.0195
282 ARTHRITIS 1536 0.0195
283 VITAMIN B12 DEFICIENCY 79 0.0195
284 PRODUCTIVE COUGH 928 0.0194
285 HEMIPLEGIA 161 0.0193
286 ULCER 305 0.0192
287 VIRAL UPPER RESPIRATORY TRACT INFECTION 91 0.0191
288 FREQUENT BOWEL MOVEMENTS 513 0.0190
289 VAGINAL DISCHARGE 192 0.0190
290 DISABILITY 374 0.0189
291 BLOOD PRESSURE INCREASED 2868 0.0187
292 ANAPHYLACTOID REACTION 77 0.0187
293 STREPTOCOCCAL INFECTION 104 0.0187
294 AFFECT LABILITY 179 0.0186
295 PHARYNGITIS 230 0.0185
296 ARTHROPOD BITE 137 0.0185
297 HYPOAESTHESIA 2760 0.0184
298 GASTROINTESTINAL TOXICITY 88 0.0183
299 COVID-19 PNEUMONIA 216 0.0183
300 ORAL INFECTION 71 0.0181
301 COMPLETED SUICIDE 1507 0.0181
302 PYREXIA 6255 0.0181
303 TOOTH FRACTURE 199 0.0180
304 BREATH SOUNDS ABNORMAL 89 0.0180
305 HORDEOLUM 78 0.0180
306 MOUTH SWELLING 104 0.0180
307 FOOD POISONING 96 0.0179
308 DYSPEPSIA 1752 0.0178
309 RASH ERYTHEMATOUS 851 0.0178
310 ARTHRALGIA 7342 0.0176
311 MUSCULAR WEAKNESS 2005 0.0176
312 AMNESIA 1144 0.0176
313 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 844 0.0176
314 MOTOR DYSFUNCTION 179 0.0175
315 VIRAL INFECTION 584 0.0175
316 INTERVERTEBRAL DISC DEGENERATION 159 0.0172
317 SNEEZING 385 0.0171
318 MENINGITIS ASEPTIC 77 0.0171
319 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 294 0.0171
320 SLEEP APNOEA SYNDROME 327 0.0171
321 LOCALISED INFECTION 412 0.0170
322 VASCULAR DEVICE INFECTION 77 0.0170
323 APHTHOUS ULCER 131 0.0169
324 HEART RATE INCREASED 1669 0.0168
325 MUSCLE TWITCHING 387 0.0168
326 ANGIOPATHY 94 0.0168
327 RASH 7281 0.0167
328 VENTRICULAR TACHYCARDIA 275 0.0166
329 PRURITUS 6380 0.0166
330 TEMPERATURE INTOLERANCE 171 0.0166
331 SPUTUM DISCOLOURED 156 0.0164
332 TACHYCARDIA 1460 0.0164
333 GASTROINTESTINAL INFECTION 145 0.0162
334 KIDNEY INFECTION 317 0.0161
335 BACK DISORDER 262 0.0161
336 MEDICATION ERROR 895 0.0161
337 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 132 0.0160
338 VEIN DISORDER 80 0.0160
339 POST PROCEDURAL INFECTION 130 0.0160
340 JOINT INJURY 337 0.0158
341 NECK PAIN 879 0.0157
342 SINUS HEADACHE 93 0.0156
343 TONGUE DISORDER 113 0.0156
344 LIGAMENT SPRAIN 154 0.0156
345 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1107 0.0155
346 GASTROOESOPHAGEAL REFLUX DISEASE 1252 0.0155
347 SWELLING OF EYELID 97 0.0154
348 NEUTROPHIL COUNT INCREASED 158 0.0154
349 SPINAL DISORDER 145 0.0153
350 VITAMIN D DEFICIENCY 149 0.0153
351 NASAL CONGESTION 897 0.0152
352 WHITE BLOOD CELL COUNT INCREASED 582 0.0152
353 SCRATCH 160 0.0152
354 RESPIRATORY SYNCYTIAL VIRUS INFECTION 132 0.0151
355 FLUID RETENTION 771 0.0151
356 SARCOIDOSIS 72 0.0151
357 POISONING 189 0.0150
358 PRODUCT USE ISSUE 2824 0.0150
359 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 77 0.0150
360 EYE PRURITUS 502 0.0149
361 SKIN PLAQUE 126 0.0149
362 ABDOMINAL PAIN UPPER 3061 0.0149
363 COVID-19 2599 0.0148
364 ANAPHYLACTIC REACTION 816 0.0148
365 TOXICITY TO VARIOUS AGENTS 2481 0.0147
366 GINGIVITIS 79 0.0146
367 HEREDITARY ANGIOEDEMA 157 0.0146
368 PNEUMONIA 4736 0.0146
369 RECTAL HAEMORRHAGE 625 0.0145
370 HEART RATE ABNORMAL 81 0.0145
371 SPINAL OSTEOARTHRITIS 127 0.0144
372 RESPIRATORY ARREST 398 0.0144
373 ANOSMIA 209 0.0144
374 INFLUENZA 1604 0.0144
375 BLOOD MAGNESIUM DECREASED 124 0.0144
376 POSTOPERATIVE WOUND INFECTION 97 0.0143
377 SKIN HAEMORRHAGE 212 0.0143
378 TOOTH DISORDER 317 0.0142
379 PAIN 8755 0.0142
380 PROTEIN URINE PRESENT 71 0.0142
381 FEELING HOT 870 0.0142
382 MOUTH ULCERATION 297 0.0141
383 DERMATITIS BULLOUS 102 0.0141
384 CONJUNCTIVITIS 261 0.0141
385 TENDON DISORDER 91 0.0139
386 DRUG ABUSE 1153 0.0138
387 CATARACT 824 0.0138
388 RHINORRHOEA 892 0.0138
389 CHEST DISCOMFORT 1406 0.0137
390 HAEMATOCRIT DECREASED 272 0.0137
391 FOOT FRACTURE 259 0.0136
392 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 106 0.0136
393 PAPULE 96 0.0136
394 CYTOKINE RELEASE SYNDROME 273 0.0136
395 CHOLECYSTITIS ACUTE 77 0.0136
396 NODULE 177 0.0135
397 PROCEDURAL PAIN 374 0.0135
398 EMPHYSEMA 136 0.0135
399 EATING DISORDER 287 0.0135
400 CHEST PAIN 2496 0.0135
401 EAR DISCOMFORT 138 0.0134
402 NERVE COMPRESSION 124 0.0134
403 OROPHARYNGEAL PAIN 1242 0.0134
404 OEDEMA PERIPHERAL 1621 0.0133
405 FATIGUE 10249 0.0132
406 BLOOD URIC ACID INCREASED 76 0.0131
407 PULMONARY CONGESTION 172 0.0130
408 MEMORY IMPAIRMENT 1790 0.0130
409 PULMONARY TOXICITY 92 0.0130
410 NEURALGIA 316 0.0130
411 SKIN ULCER 335 0.0129
412 SINUS TACHYCARDIA 184 0.0129
413 MIOSIS 104 0.0129
414 THROAT TIGHTNESS 350 0.0129
415 INSOMNIA 3444 0.0129
416 COUGH 3611 0.0129
417 HEMIPARESIS 218 0.0129
418 PSEUDOMONAS INFECTION 110 0.0128
419 HEPATITIS 328 0.0128
420 FLANK PAIN 120 0.0128
421 DYSPNOEA 7246 0.0128
422 RASH MACULO-PAPULAR 284 0.0128
423 PEMPHIGOID 96 0.0127
424 SCAB 145 0.0127
425 WEIGHT DECREASED 3536 0.0127
426 PARAESTHESIA 1976 0.0125
427 PERIORBITAL SWELLING 71 0.0125
428 EOSINOPHILIA 220 0.0125
429 THERMAL BURN 89 0.0125
430 SYMPTOM RECURRENCE 75 0.0125
431 HYPOKALAEMIA 578 0.0125
432 PULMONARY MASS 186 0.0125
433 COLITIS ULCERATIVE 558 0.0125
434 MUSCULOSKELETAL CHEST PAIN 193 0.0125
435 BLOOD CALCIUM DECREASED 140 0.0124
436 DIVERTICULITIS 345 0.0124
437 OROPHARYNGEAL DISCOMFORT 112 0.0124
438 LIMB INJURY 336 0.0124
439 HYPERTRANSAMINASAEMIA 86 0.0124
440 PNEUMONIA BACTERIAL 113 0.0123
441 IMPAIRED GASTRIC EMPTYING 167 0.0122
442 BREAST MASS 82 0.0122
443 HERPES ZOSTER 700 0.0122
444 SWOLLEN TONGUE 380 0.0122
445 CARDIO-RESPIRATORY ARREST 508 0.0121
446 CANDIDA INFECTION 205 0.0121
447 MYASTHENIA GRAVIS 98 0.0121
448 SWELLING FACE 787 0.0121
449 SOMNAMBULISM 79 0.0120
450 FUNGAL INFECTION 400 0.0120
451 ILLNESS 1236 0.0120
452 HEADACHE 7487 0.0119
453 EYE DISCHARGE 124 0.0119
454 INTENTIONAL OVERDOSE 765 0.0119
455 POISONING DELIBERATE 113 0.0119
456 CONDITION AGGRAVATED 3615 0.0119
457 MASS 166 0.0119
458 COGNITIVE DISORDER 554 0.0119
459 HYPERTHERMIA 90 0.0118
460 LACRIMATION INCREASED 355 0.0117
461 BLOOD UREA INCREASED 195 0.0116
462 CONCUSSION 90 0.0116
463 RASH PRURITIC 629 0.0116
464 HYPERHIDROSIS 1494 0.0116
465 URINARY TRACT INFECTION 1971 0.0115
466 BACK PAIN 2674 0.0115
467 BLOOD PRESSURE ABNORMAL 228 0.0115
468 MALAISE 5027 0.0115
469 ANXIETY 3262 0.0115
470 CELLULITIS 577 0.0114
471 VOMITING 5364 0.0114
472 DIPLOPIA 296 0.0114
473 APHONIA 159 0.0114
474 NASAL DRYNESS 71 0.0113
475 LYMPHOCYTE COUNT DECREASED 200 0.0113
476 DYSPNOEA EXERTIONAL 425 0.0113
477 BASAL CELL CARCINOMA 176 0.0113
478 EOSINOPHIL COUNT INCREASED 94 0.0113
479 ORAL HERPES 220 0.0113
480 OCULAR HYPERAEMIA 534 0.0112
481 ABDOMINAL PAIN 2617 0.0112
482 MUSCLE SPASMS 2064 0.0112
483 DEPRESSION 2552 0.0112
484 DRY THROAT 114 0.0112
485 ELECTROCARDIOGRAM QT PROLONGED 403 0.0112
486 PAIN IN EXTREMITY 3297 0.0112
487 COLITIS 424 0.0112
488 HYPOTENSION 2242 0.0112
489 DRUG ERUPTION 198 0.0112
490 INTENTIONAL PRODUCT MISUSE 978 0.0112
491 BRAIN FOG 175 0.0112
492 DECREASED APPETITE 2585 0.0111
493 VITAMIN D DECREASED 95 0.0111
494 DECREASED IMMUNE RESPONSIVENESS 109 0.0111
495 BACTERIAL INFECTION 207 0.0111
496 DYSARTHRIA 417 0.0111
497 FULL BLOOD COUNT ABNORMAL 117 0.0111
498 ERYTHEMA 2260 0.0110
499 THERAPEUTIC RESPONSE DECREASED 665 0.0110
500 WRIST FRACTURE 131 0.0109
501 PALPITATIONS 1278 0.0109
502 HAND FRACTURE 77 0.0109
503 CARDIAC MURMUR 94 0.0109
504 RASH PAPULAR 243 0.0108
505 ROTATOR CUFF SYNDROME 139 0.0108
506 FEBRILE NEUTROPENIA 718 0.0108
507 ADVERSE REACTION 143 0.0108
508 SECRETION DISCHARGE 135 0.0108
509 MUSCLE STRAIN 93 0.0107
510 MUCOSAL INFLAMMATION 281 0.0107
511 IMPAIRED QUALITY OF LIFE 154 0.0107
512 SENSITIVE SKIN 79 0.0107
513 SCAR 183 0.0107
514 DYSPHAGIA 1008 0.0106
515 PRODUCT USE IN UNAPPROVED INDICATION 2631 0.0106
516 ASPIRATION 116 0.0106
517 DERMATITIS ALLERGIC 133 0.0106
518 INTERVERTEBRAL DISC PROTRUSION 231 0.0106
519 HYPOMAGNESAEMIA 147 0.0105
520 LYMPHOEDEMA 73 0.0105
521 GASTROENTERITIS 154 0.0105
522 RED BLOOD CELL COUNT DECREASED 301 0.0105
523 HIATUS HERNIA 136 0.0105
524 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 548 0.0105
525 BLOOD POTASSIUM DECREASED 315 0.0105
526 RENAL CYST 83 0.0104
527 ANGINA PECTORIS 299 0.0104
528 TOXIC SKIN ERUPTION 105 0.0104
529 EYE SWELLING 387 0.0104
530 MUSCULOSKELETAL DISCOMFORT 179 0.0104
531 APHASIA 314 0.0104
532 RESTLESS LEGS SYNDROME 189 0.0104
533 BLOOD IRON DECREASED 123 0.0104
534 ASTHENIA 3890 0.0103
535 UROSEPSIS 95 0.0103
536 MIDDLE INSOMNIA 192 0.0103
537 ATELECTASIS 99 0.0102
538 HYPOAESTHESIA ORAL 154 0.0102
539 DENTAL CARIES 113 0.0102
540 PHOTOPHOBIA 192 0.0102
541 PHOTOSENSITIVITY REACTION 168 0.0102
542 SKIN REACTION 143 0.0101
543 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1826 0.0101
544 TINNITUS 465 0.0101
545 TRANSIENT ISCHAEMIC ATTACK 341 0.0101
546 END STAGE RENAL DISEASE 184 0.0101
547 TENDONITIS 156 0.0101
548 DISTURBANCE IN ATTENTION 543 0.0101
549 TOOTHACHE 182 0.0100
550 RIB FRACTURE 206 0.0100
551 GINGIVAL PAIN 79 0.0099
552 INTENTIONAL SELF-INJURY 200 0.0099
553 BLOOD TEST ABNORMAL 139 0.0099
554 HEPATOCELLULAR INJURY 140 0.0099
555 URINARY RETENTION 329 0.0099
556 CARPAL TUNNEL SYNDROME 138 0.0098
557 DEPRESSED MOOD 520 0.0098
558 HEPATIC STEATOSIS 182 0.0098
559 SARS-COV-2 TEST POSITIVE 129 0.0098
560 PERIPHERAL COLDNESS 134 0.0097
561 HEART RATE IRREGULAR 220 0.0097
562 SINUS BRADYCARDIA 94 0.0097
563 ADVERSE DRUG REACTION 872 0.0097
564 HEPATOTOXICITY 216 0.0097
565 GALLBLADDER DISORDER 173 0.0097
566 UPPER LIMB FRACTURE 193 0.0097
567 RETCHING 206 0.0097
568 ADVERSE EVENT 890 0.0096
569 SUPRAVENTRICULAR TACHYCARDIA 92 0.0096
570 GAIT DISTURBANCE 1825 0.0095
571 VENTRICULAR EXTRASYSTOLES 99 0.0095
572 HYPOALBUMINAEMIA 74 0.0095
573 SOMNOLENCE 1911 0.0095
574 OSTEOPENIA 144 0.0095
575 BLOOD URINE PRESENT 180 0.0095
576 UNRESPONSIVE TO STIMULI 244 0.0094
577 OFF LABEL USE 8269 0.0094
578 CHILLS 1106 0.0094
579 PLATELET COUNT INCREASED 123 0.0094
580 DIZZINESS 4693 0.0094
581 INJECTION SITE EXTRAVASATION 116 0.0094
582 EYELID OEDEMA 109 0.0094
583 FACE OEDEMA 158 0.0094
584 NEPHROLITHIASIS 429 0.0093
585 INCREASED TENDENCY TO BRUISE 86 0.0093
586 BLOOD ALBUMIN DECREASED 74 0.0093
587 BLOOD PRESSURE DECREASED 619 0.0093
588 CARDIAC ARREST 769 0.0093
589 SLUGGISHNESS 95 0.0093
590 PSORIASIS 1212 0.0093
591 HYPOXIA 326 0.0092
592 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 238 0.0092
593 VISUAL IMPAIRMENT 1144 0.0092
594 TOXIC EPIDERMAL NECROLYSIS 140 0.0092
595 NAUSEA 7294 0.0092
596 PETECHIAE 96 0.0092
597 HYPOTHERMIA 93 0.0092
598 ELECTROCARDIOGRAM ABNORMAL 72 0.0092
599 FALL 3052 0.0092
600 AGITATION 673 0.0092
601 MYOPATHY 79 0.0091
602 ACCIDENT 109 0.0091
603 EYE INFLAMMATION 87 0.0091
604 INFLUENZA LIKE ILLNESS 750 0.0091
605 APPENDICITIS 85 0.0091
606 DIARRHOEA 5855 0.0091
607 LYMPHADENOPATHY 321 0.0091
608 POST PROCEDURAL COMPLICATION 174 0.0091
609 TACHYPNOEA 123 0.0090
610 HYPONATRAEMIA 509 0.0090
611 DRY EYE 446 0.0089
612 ORAL PAIN 200 0.0089
613 POOR QUALITY SLEEP 192 0.0089
614 SKIN LESION 244 0.0089
615 ACUTE RESPIRATORY DISTRESS SYNDROME 157 0.0089
616 ESCHERICHIA INFECTION 73 0.0089
617 GASTRITIS 233 0.0088
618 ABDOMINAL DISTENSION 923 0.0088
619 BLOOD ALKALINE PHOSPHATASE INCREASED 219 0.0088
620 CHRONIC KIDNEY DISEASE 669 0.0088
621 GOUT 157 0.0087
622 PRESYNCOPE 212 0.0087
623 LUNG INFILTRATION 77 0.0087
624 HAEMOPTYSIS 243 0.0087
625 PURPURA 77 0.0087
626 FEELING COLD 242 0.0087
627 PAIN OF SKIN 233 0.0086
628 HEPATOMEGALY 85 0.0086
629 ALANINE AMINOTRANSFERASE INCREASED 531 0.0086
630 FLUSHING 879 0.0086
631 QUALITY OF LIFE DECREASED 116 0.0086
632 HEAD INJURY 273 0.0086
633 BODY HEIGHT DECREASED 92 0.0086
634 PRODUCT DOSE OMISSION ISSUE 2530 0.0086
635 VERTIGO 524 0.0086
636 THROMBOCYTOPENIA 961 0.0086
637 HERNIA 166 0.0086
638 BALANCE DISORDER 734 0.0085
639 ABSCESS 135 0.0085
640 HALLUCINATION 637 0.0084
641 PHARYNGEAL OEDEMA 130 0.0084
642 ECZEMA 442 0.0084
643 PULMONARY OEDEMA 377 0.0084
644 PRURITUS GENERALISED 182 0.0084
645 CONSTIPATION 1835 0.0084
646 BONE DISORDER 153 0.0084
647 OCULAR DISCOMFORT 94 0.0084
648 RESPIRATORY DISTRESS 231 0.0084
649 HAEMORRHOIDS 163 0.0083
650 HYPERKALAEMIA 293 0.0083
651 PANCREATITIS 441 0.0083
652 LABORATORY TEST ABNORMAL 246 0.0083
653 CYANOSIS 131 0.0083
654 ECONOMIC PROBLEM 126 0.0083
655 RENAL PAIN 88 0.0083
656 CARDIOMEGALY 102 0.0083
657 CLOSTRIDIUM DIFFICILE INFECTION 181 0.0083
658 JAUNDICE 223 0.0083
659 GINGIVAL BLEEDING 113 0.0083
660 IMMUNOSUPPRESSION 73 0.0083
661 PSYCHOTIC DISORDER 244 0.0083
662 LETHARGY 475 0.0082
663 HEAD DISCOMFORT 146 0.0082
664 STAPHYLOCOCCAL INFECTION 271 0.0082
665 ANAPHYLACTIC SHOCK 211 0.0082
666 LIMB DISCOMFORT 253 0.0082
667 BLOOD CREATININE INCREASED 533 0.0082
668 EYE DISORDER 268 0.0081
669 RASH MACULAR 284 0.0081
670 DYSURIA 299 0.0081
671 ASPARTATE AMINOTRANSFERASE INCREASED 429 0.0081
672 PSYCHOMOTOR HYPERACTIVITY 134 0.0081
673 RECALLED PRODUCT ADMINISTERED 77 0.0081
674 BRONCHOSPASM 115 0.0081
675 RENAL TUBULAR NECROSIS 79 0.0080
676 PRODUCT AVAILABILITY ISSUE 183 0.0080
677 LEUKOPENIA 402 0.0080
678 HAEMATOCHEZIA 443 0.0080
679 PANCREATITIS ACUTE 180 0.0080
680 CHOKING 156 0.0080
681 CHOLELITHIASIS 262 0.0080
682 SMALL INTESTINAL OBSTRUCTION 98 0.0080
683 MENTAL STATUS CHANGES 221 0.0079
684 THERAPY PARTIAL RESPONDER 124 0.0079
685 COMA 378 0.0079
686 DYSPHONIA 464 0.0079
687 NEUROPATHY PERIPHERAL 752 0.0079
688 SUICIDE ATTEMPT 479 0.0079
689 TUBULOINTERSTITIAL NEPHRITIS 148 0.0079
690 SKIN FISSURES 154 0.0079
691 OSTEOMYELITIS 142 0.0078
692 HYPOCALCAEMIA 148 0.0078
693 CYST 97 0.0078
694 DEHYDRATION 1042 0.0078
695 SYNCOPE 781 0.0078
696 NEUTROPHIL COUNT DECREASED 317 0.0078
697 MUSCULOSKELETAL DISORDER 148 0.0078
698 RESPIRATORY DEPRESSION 95 0.0077
699 DISORIENTATION 307 0.0077
700 IRON DEFICIENCY ANAEMIA 71 0.0077
701 PALLOR 209 0.0077
702 PARANOIA 132 0.0076
703 MYOCARDIAL ISCHAEMIA 87 0.0076
704 GASTROINTESTINAL PAIN 84 0.0076
705 THERAPEUTIC RESPONSE SHORTENED 253 0.0076
706 EYE IRRITATION 439 0.0076
707 ACUTE KIDNEY INJURY 1167 0.0076
708 ANKLE FRACTURE 118 0.0076
709 EYE PAIN 430 0.0076
710 HYPERLIPIDAEMIA 91 0.0076
711 NEPHROPATHY 71 0.0076
712 ACUTE RESPIRATORY FAILURE 146 0.0076
713 BLOOD SODIUM DECREASED 143 0.0076
714 BLOOD POTASSIUM INCREASED 123 0.0076
715 BRAIN OEDEMA 95 0.0075
716 BLOOD BILIRUBIN INCREASED 203 0.0075
717 URINARY INCONTINENCE 222 0.0075
718 WITHDRAWAL SYNDROME 314 0.0075
719 ACCIDENTAL OVERDOSE 273 0.0075
720 SKIN DISORDER 248 0.0074
721 GENERALISED OEDEMA 92 0.0074
722 BURNING SENSATION 521 0.0074
723 ANHEDONIA 195 0.0074
724 INCREASED APPETITE 141 0.0074
725 BRADYCARDIA 391 0.0074
726 EPISTAXIS 551 0.0074
727 CLOSTRIDIUM DIFFICILE COLITIS 78 0.0073
728 HAEMATOMA 190 0.0073
729 GASTRIC DISORDER 251 0.0073
730 PNEUMONITIS 199 0.0073
731 PRODUCT ADMINISTRATION ERROR 146 0.0072
732 HAEMOGLOBIN DECREASED 740 0.0072
733 COLD SWEAT 127 0.0072
734 ARRHYTHMIA 341 0.0072
735 BLINDNESS 293 0.0072
736 GLAUCOMA 138 0.0072
737 THYROID DISORDER 110 0.0071
738 FEEDING DISORDER 144 0.0071
739 FOETAL EXPOSURE DURING PREGNANCY 576 0.0071
740 HYPOTHYROIDISM 226 0.0071
741 DYSTONIA 137 0.0071
742 TRANSAMINASES INCREASED 157 0.0071
743 DRUG INTERACTION 1115 0.0070
744 PRODUCT DOSE OMISSION IN ERROR 199 0.0070
745 UNDERDOSE 511 0.0070
746 TRANSFUSION 73 0.0070
747 INJECTION SITE REACTION 478 0.0069
748 MANIA 114 0.0069
749 INITIAL INSOMNIA 71 0.0069
750 LEUKOCYTOSIS 125 0.0069
751 DEVICE RELATED INFECTION 106 0.0069
752 SKIN DISCOLOURATION 316 0.0069
753 INTENTIONAL DOSE OMISSION 196 0.0069
754 FEELING JITTERY 131 0.0069
755 LYMPHOPENIA 97 0.0069
756 PERICARDIAL EFFUSION 158 0.0068
757 HYPERGLYCAEMIA 249 0.0068
758 TOOTH EXTRACTION 85 0.0068
759 SPLENOMEGALY 80 0.0068
760 LOSS OF CONSCIOUSNESS 874 0.0068
761 PLEURAL EFFUSION 415 0.0068
762 BLOOD COUNT ABNORMAL 103 0.0068
763 HOT FLUSH 510 0.0068
764 BACTERAEMIA 80 0.0067
765 DRUG INEFFECTIVE 8868 0.0067
766 OVERDOSE 1451 0.0067
767 THIRST 120 0.0067
768 DRUG LEVEL INCREASED 111 0.0067
769 IMMUNE SYSTEM DISORDER 88 0.0067
770 GLOMERULAR FILTRATION RATE DECREASED 82 0.0067
771 HYPERSOMNIA 191 0.0067
772 SEPSIS 743 0.0067
773 STEVENS-JOHNSON SYNDROME 148 0.0067
774 DEPRESSED LEVEL OF CONSCIOUSNESS 263 0.0066
775 HYPERCALCAEMIA 82 0.0066
776 SPINAL FRACTURE 133 0.0066
777 WHITE BLOOD CELL COUNT DECREASED 717 0.0066
778 AGGRESSION 331 0.0066
779 DIABETES MELLITUS INADEQUATE CONTROL 117 0.0066
780 MYALGIA 1123 0.0066
781 ORTHOSTATIC HYPOTENSION 115 0.0066
782 CRYING 240 0.0066
783 HEPATIC CYTOLYSIS 84 0.0066
784 GAMMA-GLUTAMYLTRANSFERASE INCREASED 146 0.0066
785 DERMATITIS 138 0.0066
786 HALLUCINATION, VISUAL 139 0.0066
787 DECREASED ACTIVITY 71 0.0066
788 SEIZURE 760 0.0066
789 MICTURITION URGENCY 75 0.0066
790 CHROMATURIA 148 0.0065
791 PNEUMONIA ASPIRATION 163 0.0065
792 CIRCULATORY COLLAPSE 111 0.0065
793 METABOLIC ACIDOSIS 208 0.0065
794 SKIN CANCER 140 0.0065
795 ATRIAL FIBRILLATION 629 0.0065
796 NEOPLASM 74 0.0064
797 SUICIDAL IDEATION 589 0.0064
798 PANIC ATTACK 233 0.0064
799 SKIN EXFOLIATION 539 0.0064
800 NIGHTMARE 221 0.0064
801 ANGER 215 0.0064
802 GENERALISED TONIC-CLONIC SEIZURE 105 0.0063
803 SEPTIC SHOCK 275 0.0063
804 GASTRIC ULCER 120 0.0063
805 CHOLECYSTITIS 75 0.0063
806 RESTLESSNESS 230 0.0063
807 TREMOR 1043 0.0063
808 CHOLESTASIS 120 0.0062
809 PAIN IN JAW 177 0.0062
810 DELUSION 97 0.0062
811 INCORRECT PRODUCT ADMINISTRATION DURATION 135 0.0062
812 SEDATION 163 0.0062
813 INTERNATIONAL NORMALISED RATIO INCREASED 177 0.0062
814 DIABETES MELLITUS 473 0.0062
815 SCHIZOPHRENIA 75 0.0062
816 PROTEINURIA 117 0.0061
817 ANAEMIA 1171 0.0061
818 RHABDOMYOLYSIS 256 0.0061
819 PANCYTOPENIA 342 0.0061
820 MUSCLE TIGHTNESS 99 0.0061
821 FEELING ABNORMAL 1461 0.0061
822 ALTERED STATE OF CONSCIOUSNESS 131 0.0060
823 DEVICE OCCLUSION 85 0.0060
824 PRODUCT USE COMPLAINT 95 0.0060
825 INTERSTITIAL LUNG DISEASE 291 0.0060
826 DEMENTIA 167 0.0060
827 RESPIRATORY FAILURE 434 0.0059
828 SPEECH DISORDER 310 0.0059
829 NERVOUSNESS 309 0.0059
830 NEEDLE ISSUE 172 0.0059
831 LIVER FUNCTION TEST ABNORMAL 171 0.0059
832 BONE DENSITY DECREASED 184 0.0059
833 EJECTION FRACTION DECREASED 91 0.0058
834 HALLUCINATION, AUDITORY 93 0.0058
835 MOOD ALTERED 159 0.0058
836 MOVEMENT DISORDER 187 0.0058
837 RENAL FAILURE 771 0.0058
838 PNEUMOTHORAX 91 0.0057
839 MULTI-ORGAN FAILURE 99 0.0057
840 COMPLICATION ASSOCIATED WITH DEVICE 83 0.0057
841 PARALYSIS 81 0.0057
842 THINKING ABNORMAL 105 0.0056
843 APATHY 82 0.0056
844 IRRITABILITY 337 0.0056
845 CARDIOGENIC SHOCK 79 0.0055
846 BLOOD CREATINE PHOSPHOKINASE INCREASED 158 0.0055
847 DEEP VEIN THROMBOSIS 355 0.0055
848 RENAL DISORDER 253 0.0054
849 HYPOPHAGIA 138 0.0054
850 HIP FRACTURE 173 0.0054
851 PLATELET COUNT DECREASED 571 0.0054
852 FAECES DISCOLOURED 116 0.0053
853 FLATULENCE 303 0.0053
854 INTENTIONAL DRUG MISUSE 111 0.0053
855 HYPOGLYCAEMIA 257 0.0053
856 PULMONARY EMBOLISM 503 0.0053
857 BONE PAIN 310 0.0053
858 SEROTONIN SYNDROME 101 0.0053
859 THROMBOSIS 421 0.0052
860 VISION BLURRED 718 0.0052
861 NEUTROPENIA 711 0.0052
862 ACUTE HEPATIC FAILURE 71 0.0052
863 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 284 0.0052
864 SENSORY DISTURBANCE 83 0.0052
865 COAGULOPATHY 86 0.0052
866 DEAFNESS 134 0.0051
867 DYSKINESIA 208 0.0051
868 AGEUSIA 127 0.0051
869 LYMPHOMA 78 0.0050
870 SHOCK 116 0.0050
871 RENAL FAILURE ACUTE 214 0.0050
872 RASH GENERALISED 130 0.0050
873 DISEASE RECURRENCE 238 0.0050
874 PULMONARY HYPERTENSION 104 0.0050
875 LUNG INFECTION 77 0.0050
876 CORONARY ARTERY DISEASE 150 0.0049
877 FEAR 133 0.0049
878 FEMUR FRACTURE 153 0.0049
879 PRODUCT QUALITY ISSUE 663 0.0049
880 MULTIPLE SCLEROSIS 233 0.0049
881 MENTAL DISORDER 212 0.0049
882 RENAL IMPAIRMENT 409 0.0049
883 FULL BLOOD COUNT DECREASED 98 0.0049
884 MELAENA 107 0.0049
885 DRY SKIN 643 0.0048
886 UPPER GASTROINTESTINAL HAEMORRHAGE 81 0.0048
887 ABDOMINAL PAIN LOWER 121 0.0048
888 ABNORMAL BEHAVIOUR 189 0.0048
889 HAEMATURIA 162 0.0047
890 DYSSTASIA 138 0.0047
891 INTESTINAL OBSTRUCTION 178 0.0047
892 AGRANULOCYTOSIS 87 0.0047
893 DERMATITIS ATOPIC 245 0.0046
894 PRODUCT PRESCRIBING ERROR 110 0.0046
895 BLOOD LACTATE DEHYDROGENASE INCREASED 73 0.0046
896 POLLAKIURIA 192 0.0046
897 ENCEPHALOPATHY 113 0.0046
898 MOOD SWINGS 145 0.0045
899 CARDIAC DISORDER 423 0.0045
900 ABNORMAL DREAMS 124 0.0045
901 IMPAIRED WORK ABILITY 95 0.0044
902 BLOOD GLUCOSE ABNORMAL 82 0.0044
903 HOSPITALISATION 682 0.0044
904 NEOPLASM MALIGNANT 296 0.0044
905 DYSGEUSIA 326 0.0044
906 CEREBRAL HAEMORRHAGE 157 0.0044
907 HEPATIC FAILURE 132 0.0044
908 MULTIPLE ORGAN DYSFUNCTION SYNDROME 124 0.0044
909 EMOTIONAL DISORDER 134 0.0043
910 CONVULSION 245 0.0043
911 BONE MARROW FAILURE 87 0.0043
912 PRODUCT PRESCRIBING ISSUE 93 0.0043
913 NERVOUS SYSTEM DISORDER 133 0.0043
914 ASCITES 125 0.0042
915 BLOOD GLUCOSE DECREASED 204 0.0042
916 RENAL INJURY 126 0.0042
917 ACUTE MYOCARDIAL INFARCTION 125 0.0042
918 HAEMATEMESIS 107 0.0042
919 CARDIAC FAILURE CONGESTIVE 339 0.0042
920 BLOOD GLUCOSE INCREASED 792 0.0042
921 BLOOD TRIGLYCERIDES INCREASED 74 0.0042
922 TREATMENT NONCOMPLIANCE 227 0.0041
923 TOOTH LOSS 86 0.0041
924 PELVIC PAIN 74 0.0041
925 LACTIC ACIDOSIS 129 0.0040
926 CARDIAC FAILURE 314 0.0039
927 LUNG NEOPLASM MALIGNANT 160 0.0039
928 HAEMORRHAGE 405 0.0039
929 EMOTIONAL DISTRESS 465 0.0038
930 GLYCOSYLATED HAEMOGLOBIN INCREASED 95 0.0038
931 HEPATIC FUNCTION ABNORMAL 138 0.0037
932 GASTROINTESTINAL HAEMORRHAGE 307 0.0037
933 CEREBROVASCULAR ACCIDENT 620 0.0037
934 OSTEONECROSIS 119 0.0036
935 MENTAL IMPAIRMENT 87 0.0036
936 CARDIOVASCULAR DISORDER 91 0.0036
937 INJECTION SITE RASH 107 0.0035
938 THERAPEUTIC RESPONSE UNEXPECTED 156 0.0035
939 THERAPY INTERRUPTED 246 0.0034
940 INJECTION SITE SWELLING 263 0.0034
941 PHARMACEUTICAL PRODUCT COMPLAINT 89 0.0034
942 MYOCARDIAL INFARCTION 596 0.0034
943 DISEASE PROGRESSION 401 0.0034
944 ABORTION SPONTANEOUS 135 0.0034
945 HYPOACUSIS 144 0.0033
946 TARDIVE DYSKINESIA 93 0.0033
947 DIABETIC KETOACIDOSIS 77 0.0032
948 EXPIRED PRODUCT ADMINISTERED 106 0.0032
949 PRODUCT SUBSTITUTION ISSUE 182 0.0032
950 ERECTILE DYSFUNCTION 81 0.0032
951 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 73 0.0031
952 THERAPY CESSATION 158 0.0031
953 UNEVALUABLE EVENT 232 0.0031
954 SURGERY 175 0.0030
955 EXTRAPYRAMIDAL DISORDER 74 0.0030
956 INCORRECT DOSE ADMINISTERED 674 0.0029
957 ACNE 217 0.0029
958 VISUAL ACUITY REDUCED 94 0.0028
959 INJECTION SITE PRURITUS 188 0.0028
960 INJECTION SITE ERYTHEMA 342 0.0028
961 PLASMA CELL MYELOMA 105 0.0027
962 EXTRA DOSE ADMINISTERED 109 0.0027
963 DEATH 2204 0.0026
964 SKIN IRRITATION 116 0.0025
965 INJECTION SITE BRUISING 201 0.0025
966 PREMATURE BABY 75 0.0025
967 NO ADVERSE EVENT 448 0.0025
968 SKIN BURNING SENSATION 177 0.0025
969 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 82 0.0024
970 NEOPLASM PROGRESSION 82 0.0024
971 MULTIPLE SCLEROSIS RELAPSE 159 0.0023
972 INJECTION SITE MASS 85 0.0023
973 DRUG EFFECT DECREASED 119 0.0022
974 INJECTION SITE PAIN 676 0.0022
975 MYELOSUPPRESSION 78 0.0022
976 VAGINAL HAEMORRHAGE 93 0.0021
977 DEVICE BREAKAGE 86 0.0021
978 DEVICE ISSUE 189 0.0021
979 MALIGNANT NEOPLASM PROGRESSION 213 0.0021
980 BREAST CANCER 192 0.0021
981 DEVICE DISLOCATION 86 0.0020
982 DRUG WITHDRAWAL SYNDROME 170 0.0019
983 PRODUCT DOSE OMISSION 121 0.0019
984 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 360 0.0018
985 DEVICE LEAKAGE 76 0.0018
986 DRUG DEPENDENCE 267 0.0017
987 DEVICE MALFUNCTION 110 0.0016
988 INJECTION SITE HAEMORRHAGE 121 0.0015
989 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 103 0.0014
990 DRUG DOSE OMISSION 234 0.0014
991 ACCIDENTAL EXPOSURE TO PRODUCT 133 0.0013
992 PRODUCT STORAGE ERROR 93 0.0011
993 PROSTATE CANCER 71 0.0009